Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 8BAYER HLTHCARE
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22574
Patent Use Code : U-1
Delist Requested :
Patent Use Description : PREVENTION OF PREGNANC...
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22574
Patent Use Code : U-3572
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code : U-1
Delist Requested :
Patent Use Description : PREVENTION OF PREGNANC...
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code : U-3572
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code : U-3573
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code : U-3574
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-02-08
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 8617597
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22574
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-02-08
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-02-08
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 8617597
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-02-08
